| Piperidine | C5H11N | 85.15 g/mol | 1 | 1 / 1 | Six-membered saturated cyclic secondary amine; widely used as a versatile nitrogen-containing core. | Pharmaceutical intermediates Agrochemical synthesis Medicinal chemistry | Confirm assay, water content, residual solvents, odor profile, salt form, and packaging compatibility. |
| Piperazine | C4H10N2 | 86.14 g/mol | 2 | 2 / 2 | Symmetrical diamine ring that can improve polarity, salt formation, and aqueous handling in drug-like molecules. | API intermediates Salt formation Medicinal chemistry | Check stereochemical and positional specifications where applicable, assay by validated method, and control of inorganic residues. |
| 4-Methylpiperidine | C6H13N | 99.18 g/mol | 1 | 1 / 1 | Hydrophobic-substituted piperidine used to tune steric bulk, lipophilicity, and conformational properties. | Lead optimization API intermediates Custom synthesis | Verify regioisomer purity, water content, residual starting materials, and concentration or salt-form consistency. |
| 4-Hydroxypiperidine | C5H11NO | 101.15 g/mol | 1 | 2 / 2 | Bifunctional amino alcohol that provides a basic nitrogen and an alcohol handle for further derivatization. | Medicinal chemistry Linker design Heterocycle synthesis | Distinguish free base from hydrochloride or other salts; monitor water, residual solvents, and oxidation-sensitive impurities. |
| 4-Aminopiperidine | C5H12N2 | 100.17 g/mol | 2 | 2 / 2 | Diamine building block with two orthogonal nitrogen functionalities for amide, urea, sulfonamide, and alkylation chemistry. | Pharmaceutical discovery Bifunctional linkers API development | Control regioisomeric impurities, salt form, amine functionality, water content, and residual protecting-group by-products. |
| N-Methylpiperazine | C5H12N2 | 100.17 g/mol | 2 | 1 / 2 | N-substituted piperazine that combines a secondary amine reaction site with a tertiary amine for polarity and salt formation. | API intermediates Solubility optimization Late-stage functionalization | Confirm N-substitution selectivity, assay, residual methylating agents, water, and the specified salt or free-base form. |
| 1-(2-Hydroxyethyl)piperazine | C6H14N2O | 130.19 g/mol | 2 | 1 / 3 | Hydroxy-functionalized piperazine offering a basic ring and a terminal alcohol for coupling or linker construction. | Drug-linker chemistry Polymer additives Specialty intermediates | Evaluate mono-substitution selectivity, di-substituted impurities, water, residual solvents, and hydroxyl-group assay. |
| 2-Methylpiperazine | C5H12N2 | 100.17 g/mol | 2 | 2 / 2 | Methyl-substituted diamine scaffold used to introduce asymmetry and adjust steric and physicochemical properties. | Medicinal chemistry API intermediates Structure–activity studies | Specify stereochemical composition when relevant and test for positional isomers, assay, water, and residual amine impurities. |